Literature DB >> 18072162

Lithium toxicity from an Internet dietary supplement.

D K Pauzé1, D E Brooks.   

Abstract

INTRODUCTION: The widespread availability of medications and herbal products on the Internet has increased the potential for poisonings. We are reporting a case of mild, acute lithium toxicity occurring after the intentional misuse of a lithium-containing "dietary supplement" (Find Serenity Now) obtained over the Internet. CASE REPORT: An 18-year-old woman presented to our emergency department (ED) after ingesting 18 tablets of Find Serenity Now; each tablet contained, according to the listing, 120 mg of lithium orotate [3.83 mg of elemental lithium per 100 mg of (organic) lithium orotate compared to 18.8 mg of elemental lithium per 100 mg of (inorganic) lithium carbonate]. The patient complained of nausea and reported one episode of emesis. Her examination revealed normal vital signs. The only finding was a mild tremor without rigidity. Almost 90 minutes after the ingestion, her serum lithium level was 0.31 mEq/L, a urine drug screen was negative, and an electrocardiogram (ECG) showed a normal sinus rhythm. The patient received intravenous fluids and an anti-emetic; one hour later, her repeat serum lithium level was 0.40 mEq/L. After 3 hours of observation, nausea and tremor were resolved, and she was subsequently transferred to a psychiatric hospital for further care. Prior human and animal data have shown similar pharmacokinetics and shared clinical effects of these lithium salts. DISCUSSION: Over-the-Internet dietary supplements may contain ingredients capable of causing toxicity in overdose. Chronic lithium toxicity from ingestion of this product is also of theoretical concern.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18072162      PMCID: PMC3550087          DOI: 10.1007/bf03160910

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  18 in total

1.  Inappropriate advertising of dietary supplements.

Authors:  Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

2.  A critical evaluation of Internet marketing of products that contain ephedra.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Carmen P Pichard
Journal:  Mayo Clin Proc       Date:  2003-08       Impact factor: 7.616

3.  Severe cyanide toxicity from 'vitamin supplements'.

Authors:  Brian O'Brien; Catherine Quigg; Tim Leong
Journal:  Eur J Emerg Med       Date:  2005-10       Impact factor: 2.799

4.  Overdose with sustained-release lithium preparations.

Authors:  B Astruc; P Petit; M Abbar
Journal:  Eur Psychiatry       Date:  1999-06       Impact factor: 5.361

Review 5.  Clinical manifestations and management of acute lithium intoxication.

Authors:  M D Okusa; L J Crystal
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

Review 6.  The use of lithium levels in the emergency department.

Authors:  A T Sadosty; G A Groleau; M M Atcherson
Journal:  J Emerg Med       Date:  1999 Sep-Oct       Impact factor: 1.484

7.  Lithium toxicity: an iatrogenic problem in susceptible individuals.

Authors:  P W Oakley; I M Whyte; G L Carter
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

Review 8.  Irreversible lithium neurotoxicity: an overview.

Authors:  B Kores; M H Lader
Journal:  Clin Neuropharmacol       Date:  1997-08       Impact factor: 1.592

9.  Acute lithium intoxication and neuroleptic malignant syndrome.

Authors:  Jasleen Gill; Harmohan Singh; Kenneth Nugent
Journal:  Pharmacotherapy       Date:  2003-06       Impact factor: 4.705

10.  Cyberpharmacies and the role of the US Food And Drug Administration.

Authors:  J E Henney
Journal:  J Med Internet Res       Date:  2001 Jan-Mar       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.